IRTC iRhythm Technologies Inc

Price (delayed)

$111.91

Market cap

$3.47B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.04

Enterprise value

$3.56B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
The revenue has grown by 20% YoY and by 4.2% from the previous quarter
The company's gross profit rose by 18% YoY and by 2.7% QoQ
The quick ratio has contracted by 38% YoY and by 11% from the previous quarter
The company's net income fell by 18% QoQ and by 6% YoY

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
30.98M
Market cap
$3.47B
Enterprise value
$3.56B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
16.33
Price to sales (P/S)
6.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.23
Earnings
Revenue
$492.68M
EBIT
-$119.01M
EBITDA
-$96.86M
Free cash flow
-$90.53M
Per share
EPS
-$4.04
Free cash flow per share
-$2.97
Book value per share
$6.85
Revenue per share
$16.14
TBVPS
$14.16
Balance sheet
Total assets
$433.14M
Total liabilities
$223.05M
Debt
$129.82M
Equity
$210.1M
Working capital
$123.44M
Liquidity
Debt to equity
0.62
Current ratio
2.15
Quick ratio
1.82
Net debt/EBITDA
-0.97
Margins
EBITDA margin
-19.7%
Gross margin
67.3%
Net margin
-25%
Operating margin
-25.4%
Efficiency
Return on assets
-28.6%
Return on equity
-56.4%
Return on invested capital
-28.6%
Return on capital employed
-36.5%
Return on sales
-24.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
0.58%
1 week
-0.16%
1 month
-2.69%
1 year
-17.35%
YTD
4.55%
QTD
-3.53%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$492.68M
Gross profit
$331.81M
Operating income
-$125.16M
Net income
-$123.41M
Gross margin
67.3%
Net margin
-25%
The revenue has grown by 20% YoY and by 4.2% from the previous quarter
The company's net income fell by 18% QoQ and by 6% YoY
The company's gross profit rose by 18% YoY and by 2.7% QoQ
The operating income has contracted by 17% from the previous quarter and by 10% YoY

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
16.33
P/S
6.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.23
The EPS has decreased by 17% from the previous quarter and by 4.1% YoY
IRTC's equity is down by 12% year-on-year and by 4.4% since the previous quarter
IRTC's P/B is 9% above its last 4 quarters average of 15.0
The P/S is 37% below the 5-year quarterly average of 11.0 and 2.4% below the last 4 quarters average of 7.1
The revenue has grown by 20% YoY and by 4.2% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has decreased by 22% from the previous quarter and by 18% YoY
The ROA has contracted by 19% from the previous quarter and by 8% YoY
IRTC's return on invested capital is down by 18% since the previous quarter and by 4% year-on-year
The ROS has decreased by 14% from the previous quarter but it has increased by 11% YoY

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 94% greater than its total liabilities
The quick ratio has contracted by 38% YoY and by 11% from the previous quarter
The current ratio has declined by 34% year-on-year and by 6% since the previous quarter
The debt is 38% less than the equity
The debt to equity has grown by 13% YoY and by 3.3% from the previous quarter
IRTC's equity is down by 12% year-on-year and by 4.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.